October 09, 2014
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Mazor granted CFDA approval for surgical guidance system
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Mazor Robotics announced that the China Food and Drug Administration has approved the company’s Renaissance surgical guidance system, designed to enable surgeons to conduct spine surgeries in an accurate and secure manner.
The company’s Chinese distribution partner, Cicel, has coordinated seminars and hands-on lab experiences in the U.S. for China’s leading spine surgeons to learn about the Renaissance system and its clinical benefits, according to a press release from Mazor.
The Renaissance system is currently installed in seven locations across India, Hong Kong, Taiwan, Singapore, Vietnam and Australia, according to the release.
Reference: www.mazorrobotics.com.